NEOPROL
Formerly Neoprol
Intravenous Induction and Maintenance of Anesthesia
Startup Seed Health Tech & Life Sciences Est. 2014
🌐 Website
Total Raised
Undisclosed
Seed
Last Round
Undisclosed
1 rounds
Investors
1
1 public
Team
2
1-10 employees
Confidence
87/100
About
NEOPROL is the developer of a new formulation for anesthesia drugs. The companys NP-09 is an advanced preclinical development of an improved formulation and novel bioequivalent of propofol, with proven superiority over Diprivan. NEOPROLs formulation is based on an invention by Professor Nissim Garti.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
Materials & SubstancesNanomaterials
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business Model
B2B
Tags
nanotechnologypharmaceuticalslife-sciences
Funding & Events
Mar 2019
Undisclosed Round Undisclosed
Integra Holdings
Details
Product Stage
R&D
Employees
1-10
Exact Count
6
District
Jerusalem District
Founded
2014
Registrar
515124055
Crunchbase
neoprol
Locations
Givat Ram, Jerusalem, Israel
Links
Website
www.integra-holdings.com/portfolio/neoprol
Admin
Last Update
Sep 14, 2024
Verified by
Jenny Sotnik-Talisman
Missing
video or image, news, markets, external profiles, not claimed
Team (2)
Liana Patt
CEO
Lior Buchman
CFO
Internal
Created by
Natalia Golczar (ngolczar@gmail.com)
Created
2018-07-17T00:00:00.000Z
Last editor
Paul Weisko (pweisko@gmail.com)
Finder · NEOPROL · 2026